Delivery Order 75N93021D00005-75N93023F00001
Award Date
4/1/23
Potential Completion Date
3/31/24
Potential Value
$1.2M
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Starks Associates Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Buffalo, NY 14213, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
2
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $1,181,588.00 delivery order contract to Starks Associates Inc. under the Preclinical Services for HIV Therapeutics master indefinite-delivery indefinite-quantity contract. Starks Associates Inc. will conduct synthesis and acquire batches of compounds for subsequent biological in vitro and in vivo testing in support of preclinical services for HIV...
Starks Associates Inc. was awarded a $5,908.72 delivery order against the Preclinical Services for HIV Therapeutics master indefinite-delivery/indefinite-quantity (IDIQ) contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The purpose of this task order is for Starks Associates to develop and deliver a quality assurance/quality control plan and participate in a task order initiation meeting to support preclinical services for HIV therapeutics....
This is a federal contract award to Starks Associates Inc., a for-profit subchapter S corporation, by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH). The contract, valued at $15,287,463.93, is for the resynthesis of therapeutic agents for the treatment of infectious diseases. The contract is a definitive contract with a cost-plus-fixed-fee pricing type and has a completion date of September 15, 2011. The contract is set...
This task order funds the guaranteed minimum amount under the prime contractor's Preclinical Services for HIV Therapeutics contract with the National Institutes of Health's National Institute of Allergy and Infectious Diseases. Starks Associates Inc. will provide preclinical services in support of HIV therapeutic development work in Buffalo, New York for $0.00 through May 18, 2021. The underlying multiple award indefinite delivery/indefinite quantity contract vehicle was awarded on a cost-no-fee...
This is a federal contract award to Starks Associates Inc., a for-profit subchapter S corporation, by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH). The contract is for the "Synthesis of Therapeutic Agents for Treatment of Infectious Diseases" and has a ceiling value of $8,129,171.83. The contract is a definitive contract of the cost-plus-fixed-fee type. Starks Associates Inc. is the prime contractor and has...
This federal contract award, valued at $499,879.67, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Southern Research Institute, a non-profit research organization. The contract is for the identification of lead compounds to inhibit HIV, as part of NIAID's broader "In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides" program. The contract is a Delivery Order...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Southern Research Institute, a non-profit research organization. The $257,889.11 cost-plus-fixed-fee contract is for the identification of anti-HIV lead compounds, which is part of NIAID's "In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides" program. The contract has no set-aside designation and is a...
The U.S. National Institute of Allergy and Infectious Diseases (NIAID) has awarded a Cost Plus Fixed Fee delivery order contract to Southern Research Institute, a non-profit research organization, to conduct confirmatory and specialized in vitro testing and screening of interventional agents for HIV therapeutics. The award, valued at $289,458.00, is a task order under NIAID's larger Preclinical Services for HIV Therapeutics Indefinite Delivery/Indefinite Quantity (ID/IQ) contract vehicle. This...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services (HHS), to Southern Research Institute, a non-profit research organization. The $999,976 cost-plus-fixed-fee contract is for services to identify inhibitors of HIV-1 capsid dimerization as part of NIAID's In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides program. The contract has no set-aside designation and is...
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $589,132.80 delivery order against the NIAID Professional, Scientific and Technical Support Services IDIQ to Kelly Services, Inc., with Ingenesis Inc. as a major subcontractor. The order calls for support services for the Division of AIDS through January 2027 in Bethesda, Maryland, to assist NIAID's efforts researching HIV/AIDS, tuberculosis, malaria and other infectious diseases. No set-aside...